Gonadal and extra-gonadal actions of FSH glycoforms in aging
FSH 糖型在衰老过程中的性腺和性腺外作用
基本信息
- 批准号:9565031
- 负责人:
- 金额:$ 48.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-30 至 2020-08-31
- 项目状态:已结题
- 来源:
- 关键词:ActivinsAffectAffinityAgeAgingAllelesAsparagineBindingBiochemicalBiologicalBiological ProcessBone DensityBone DevelopmentCandidate Disease GeneCellsClinicalDevelopmentElderly womanEngineeringEstrusEventFemaleFertilityFollicle Stimulating HormoneFollicle Stimulating Hormone ReceptorGene Expression ProfileGeneticGenetic RecombinationGenetically Engineered MouseGenitourinary systemGlycoproteinsGoalsGonadotropin Hormone Releasing HormoneHalf-LifeHormonesHumanImpairmentIn VitroIndividualInterventionKnockout MiceLaboratoriesLeadLigandsLinkMediatingMenstrual cycleMorbidity - disease rateMusMutationOocytesOsteoclastsOvarianOvarian FollicleOvarian Granulosa CellOvaryPeptidesPerimenopausePhenotypePhysiologicalPhysiologyPituitary GlandPituitary GonadotropinsPlayPostmenopauseProductionRecombinant Follicle Stimulating HormoneRoleSerumSignal PathwaySignal TransductionSpecificitySteroidsSymptomsTamoxifenTestingTimeTissuesTransgenesUterine hemorrhageVariantVasomotorWomanWorkage relatedagedanalogbasebeta Subunit Follicle Stimulating Hormonebonebone agingbone lossbone masscell typeclinically significantfolliculogenesisgenetic approachglycosylationimprovedin vivoinhibinmolecular sizemouse modelnormal agingnovelnovel therapeuticspoor egg qualitypreventpsychologicreceptor-mediated signalingreproductive senescencesugartranslational impactyoung woman
项目摘要
The long-term goal of this project is to study mechanisms of pituitary control of ovarian and bone function in
aging women. Normal ovarian function is dependent on follicle-stimulating hormone (FSH), a pituitary derived
heterodimeric glycoprotein consisting of a α-and a β-subunit. Both the subunits are glycosylated with two N-
linked sugar chains in each subunit. This fully glycosylated form is designated FSH24. Glycosylation plays a
major role in secretion, serum half-life and biological actions of FSH. It is known that glycosylation of pituitary
gonadotropins is also estrous/menstrual cycle- and age-specific. Biochemical and physiological studies in
several species have identified unique hypo-glycosylated variants consisting of sugar chains only in the α but
either one or none on the β subunit. These variants are known as hypo-glycosylated FSH glycoforms and
designated as FSH21, FSH18 or FSH15. Most importantly, the ratio of hypo- to fully-glycosylated FSH forms is
found age-dependent, with high levels of fully-glycosylated variant predominantly present in peri/post-
menopausal women and may contribute to the aging-associated bone loss. However, the distinct in vivo
biological functions of these FSH glycoform variants are unknown in normal and aging ovarian and bone
physiology. The central hypothesis is that glycosylation on FSH is an age-related switch that changes target
tissue specificity from ovary to bone. This hypothesis will be tested using genetically engineered mouse
models in two specific Aims. In Aim 1, we will test ovarian development and function progressively with aging
using Fshb null mice expressing individual glycosylated forms of FSH. This genetic strategy will allow us to test
systematically the in vivo biological actions of each glycosylated FSH variant in ovarian physiology in the
absence of endogenous mouse FSH. In Aim 2, first, we will use the FSH glycoform-expressing mice and test
bone development as a function of aging. To unequivocally test the direct actions of FSH on bone, in one
approach, we will engineer mice in which Fshr will be selectively deleted in osteoclasts by a Cre-lox genetic
approach. In a second approach, we will develop a genetically engineered mouse line that permits creating
temporal loss of FSH at desired times. Functional analyses with these genetically altered mouse models will
identify distinct biological actions of FSH variants in vivo during ovarian aging and by extrapolation, in human
ovarian senescence. These novel mouse models will also allow us to directly test whether aging-associated
bone loss is dependent on FSH ligand or FSH receptor-mediated signaling in osteoclasts in the bone. Our
studies may unravel a novel phenomenon of age-dependent N-glycosylation switch on a pituitary glycoprotein
hormone that results in alterations in target tissue specificity (ovary versus bone) and may potentially lead to
new therapeutic options for intervention of bone loss in aging women.
该项目的长期目标是研究垂体控制卵巢和骨功能的机制
老年女性的正常卵巢功能依赖于促卵泡激素(FSH),一种垂体衍生的激素。
由 α- 和 β- 亚基组成的异二聚体糖蛋白,这两个亚基均被两个 N- 糖基化。
每个亚基中连接的糖链被称为 FSH24。
已知垂体的糖基化在 FSH 的分泌、血清半衰期和生物作用中起主要作用。
促性腺激素也是针对发情/月经周期和年龄的生化和生理学研究。
一些物种已鉴定出仅在 α 中由糖链组成的独特低糖基化变体,但
β 亚基上有一个或没有,这些变体被称为低糖基化 FSH 糖型。
指定为 FSH21、FSH18 或 FSH15 最重要的是,低糖基化 FSH 形式与完全糖基化 FSH 形式的比率为
发现年龄依赖性,高水平的完全糖基化变异主要存在于围产期/产后
更年期女性可能会导致与衰老相关的骨质流失,但体内情况截然不同。
这些 FSH 糖型变体的生物学功能在正常和老化的卵巢和骨骼中尚不清楚
生理学的中心假设是 FSH 上的糖基化是一种与年龄相关的开关,可以改变目标。
从卵巢到骨骼的组织特异性将使用基因工程小鼠进行测试。
在两个具体目标中的模型在目标 1 中,我们将随着衰老逐步测试卵巢发育和功能。
使用表达单个 FSH 糖基化形式的 Fshb 缺失小鼠,我们可以测试这种遗传策略。
历史上每个糖基化 FSH 变体在卵巢生理学中的体内生物学作用
缺乏内源性小鼠 FSH 在目标 2 中,首先,我们将使用表达 FSH 糖型的小鼠进行测试。
骨骼发育与衰老的关系 明确测试 FSH 对骨骼的直接作用。
方法,我们将设计小鼠,其中破骨细胞中的 Fshr 将通过 Cre-lox 基因选择性删除
在第二种方法中,我们将开发一种可以创造的基因工程小鼠品系。
使用这些基因小鼠模型进行 FSH 在所需时间的暂时损失。
确定 FSH 变体在卵巢衰老过程中体内的独特生物学作用,并通过推断在人类中
这些新颖的小鼠模型也将使我们能够直接测试是否与衰老相关。
骨质流失取决于骨骼中破骨细胞中 FSH 配体或 FSH 受体介导的信号传导。
研究可能揭示垂体糖蛋白上年龄依赖性 N-糖基化开关的新现象
导致靶组织特异性(卵巢与骨骼)改变的激素,并可能导致
干预老年女性骨质流失的新治疗选择。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Illustrating the coupled human-environment system for vulnerability analysis: three case studies.
说明用于脆弱性分析的耦合人类环境系统:三个案例研究。
- DOI:
- 发表时间:2003-07-08
- 期刊:
- 影响因子:11.1
- 作者:Turner 2nd, B L;Matson, Pamela A;McCarthy, James J;Corell, Robert W;Christensen, Lindsey;Eckley, Noelle;Hovelsrud;Kasperson, Jeanne X;Kasperson, Roger E;Luers, Amy;Martello, Marybeth L;Mathiesen, Svein;Naylor, Rosamond;Polsky
- 通讯作者:Polsky
The potential connectivity of waterhole networks and the effectiveness of a protected area under various drought scenarios.
水坑网络的潜在连通性和保护区在各种干旱情况下的有效性。
- DOI:
- 发表时间:2014
- 期刊:
- 影响因子:3.7
- 作者:O'Farrill, Georgina;Gauthier Schampaert, Kim;Rayfield, Bronwyn;Bodin, Örjan;Calmé, Sophie;Sengupta, Raja;Gonzalez, Andrew
- 通讯作者:Gonzalez, Andrew
Agent-based modeling of deforestation in southern Yucatan, Mexico, and reforestation in the Midwest United States.
基于代理的墨西哥尤卡坦半岛南部森林砍伐和美国中西部重新造林建模。
- DOI:
- 发表时间:2007-12-26
- 期刊:
- 影响因子:11.1
- 作者:Manson, Steven M;Evans, Tom
- 通讯作者:Evans, Tom
Ecological feedbacks following deforestation create the potential for a catastrophic ecosystem shift in tropical dry forest.
森林砍伐后的生态反馈可能会导致热带干燥森林发生灾难性的生态系统转变。
- DOI:
- 发表时间:2007-12-26
- 期刊:
- 影响因子:11.1
- 作者:Lawrence, Deborah;D'Odorico, Paolo;Diekmann, Lucy;Delonge, Marcia;Das, Rishiraj;Eaton, James
- 通讯作者:Eaton, James
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
T. RAJENDRA KUMAR其他文献
T. RAJENDRA KUMAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('T. RAJENDRA KUMAR', 18)}}的其他基金
Chemoprevention of pituitary gonadotrope tumors
垂体促性腺激素肿瘤的化学预防
- 批准号:
8596804 - 财政年份:2013
- 资助金额:
$ 48.07万 - 项目类别:
Chemoprevention of pituitary gonadotrope tumors
垂体促性腺激素肿瘤的化学预防
- 批准号:
8439002 - 财政年份:2013
- 资助金额:
$ 48.07万 - 项目类别:
Chemoprevention of pituitary gonadotrope tumors
垂体促性腺激素肿瘤的化学预防
- 批准号:
8774884 - 财政年份:2013
- 资助金额:
$ 48.07万 - 项目类别:
Chemoprevention of pituitary gonadotrope tumors
垂体促性腺激素肿瘤的化学预防
- 批准号:
9003791 - 财政年份:2013
- 资助金额:
$ 48.07万 - 项目类别:
Role of Dicer in Gonadotrope and Reproductive Function
Dicer 在促性腺激素和生殖功能中的作用
- 批准号:
8301917 - 财政年份:2012
- 资助金额:
$ 48.07万 - 项目类别:
Role of Dicer in Gonadotrope and Reproductive Function
Dicer 在促性腺激素和生殖功能中的作用
- 批准号:
8458899 - 财政年份:2012
- 资助金额:
$ 48.07万 - 项目类别:
KANSAS U COBRE: GERM CELL DEVELOPMENT IN THE ATRICHOSIS MUTANT MOUSE
KANSAS U COBRE:无生长突变小鼠生殖细胞的发育
- 批准号:
8167984 - 财政年份:2010
- 资助金额:
$ 48.07万 - 项目类别:
相似国自然基金
线上民宿房东亲和力对房客预定行为的影响机制研究——基于多源异构数据视角
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
估计和解释序列变体对蛋白质稳定性、结合亲和力以及功能的影响
- 批准号:31701136
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
RGS19对嗜酸细胞性食管炎FcεRI信号传导通路的影响及其作用机制的研究
- 批准号:81500502
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
人B组腺病毒纤毛蛋白与DSG2受体亲和力的差异及其对病毒致病力的影响研究
- 批准号:31570163
- 批准年份:2015
- 资助金额:62.0 万元
- 项目类别:面上项目
TNFalpha-OPG相互作用对骨代谢的影响
- 批准号:30340052
- 批准年份:2003
- 资助金额:9.0 万元
- 项目类别:专项基金项目
相似海外基金
BMP2/ALKs signaling system in diabetic retinopathy
BMP2/ALKs信号系统在糖尿病视网膜病变中的作用
- 批准号:
10457087 - 财政年份:2021
- 资助金额:
$ 48.07万 - 项目类别:
BMP2/ALKs signaling system in diabetic retinopathy
BMP2/ALKs信号系统在糖尿病视网膜病变中的作用
- 批准号:
10558709 - 财政年份:2021
- 资助金额:
$ 48.07万 - 项目类别:
BMP2/ALKs signaling system in diabetic retinopathy
BMP2/ALKs信号系统在糖尿病视网膜病变中的作用
- 批准号:
10333334 - 财政年份:2021
- 资助金额:
$ 48.07万 - 项目类别:
BMP2/ALKs signaling system in diabetic retinopathy
BMP2/ALKs信号系统在糖尿病视网膜病变中的作用
- 批准号:
10093052 - 财政年份:2020
- 资助金额:
$ 48.07万 - 项目类别:
BMP2/ALKs signaling system in diabetic retinopathy
BMP2/ALKs信号系统在糖尿病视网膜病变中的作用
- 批准号:
9886394 - 财政年份:2020
- 资助金额:
$ 48.07万 - 项目类别: